$109 Million is the total value of M28 Capital Management LP's 13 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | ADAGIO THERAPEUTICS INC | $29,176,000 | -29.1% | 6,398,250 | +12.9% | 26.83% | -16.5% | |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $11,700,000 | -1.0% | 5,850,000 | +55.4% | 10.76% | +16.5% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $11,354,000 | +5.0% | 715,880 | +44.5% | 10.44% | +23.6% |
| STOK | STOKE THERAPEUTICS INC | $11,097,000 | -12.2% | 527,150 | 0.0% | 10.20% | +3.3% | |
| CRIS | Buy | CURIS INC | $10,099,000 | -18.7% | 4,243,293 | +62.6% | 9.28% | -4.2% |
| TGTX | Buy | TG THERAPEUTICS INC | $9,966,000 | -0.5% | 1,047,900 | +98.8% | 9.16% | +17.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $6,816,000 | +142.0% | 82,900 | +331.8% | 6.27% | +185.0% |
| BBIO | BRIDGEBIO PHARMA INC | $4,732,000 | -39.1% | 466,200 | 0.0% | 4.35% | -28.3% | |
| LPTX | Buy | LEAP THERAPEUTICS INC | $4,663,000 | +43.9% | 2,664,400 | +166.4% | 4.29% | +69.4% |
| VERV | New | VERVE THERAPEUTICS INC | $4,073,000 | – | 178,500 | +100.0% | 3.74% | – |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $3,617,000 | -49.8% | 389,353 | -14.8% | 3.33% | -40.8% |
| PRQR | New | PROQR THERAPEUTICS N V | $907,000 | – | 1,001,800 | +100.0% | 0.83% | – |
| NEXI | NEXIMMUNE INC | $562,000 | -8.6% | 133,442 | 0.0% | 0.52% | +7.7% | |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -560,600 | -100.0% | -5.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| WAVE LIFE SCIENCES LTD | 8 | Q3 2023 | 46.4% |
| INVIVYD INC | 8 | Q3 2023 | 32.1% |
| ROCKET PHARMACEUTICALS INC | 8 | Q3 2023 | 16.6% |
| BRIDGEBIO PHARMA INC | 8 | Q3 2023 | 6.1% |
| TG THERAPEUTICS INC | 8 | Q3 2023 | 9.2% |
| NEXIMMUNE INC | 8 | Q3 2023 | 0.5% |
| STOKE THERAPEUTICS INC | 7 | Q2 2023 | 10.2% |
| CURIS INC | 7 | Q2 2023 | 9.7% |
| PROQR THRAPEUTICS N V | 7 | Q3 2023 | 6.7% |
| ATARA BIOTHERAPEUTICS INC | 5 | Q1 2023 | 5.6% |
View M28 Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adagio Therapeutics, Inc. | August 19, 2022 | 9,248,250 | 8.5% |
View M28 Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-05-25 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-10 |
View M28 Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.